Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.33 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1791619 | 0.98 | ALDH1A1 (0.38) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL14375351 | 0.78 | ALDH1A1 (0.36) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL4011812 | 0.73 | DAO (0.32) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL1924912 | 0.71 | DAO (0.31) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL19323695 | 0.71 | MAPK14 (0.32) | ALDH1A1KDM4EGLAGAAHPGD | |
| Hydrochloric Acid SCHEMBL8463457 | 0.70 | DAO (0.30) | DAO | |
| SCHEMBL2405178 | 0.70 | DAO (0.30) | DAO | |
| SCHEMBL2404545 | 0.70 | DAO (0.30) | DAO | |
| Hydrochloric Acid SCHEMBL8535246 | 0.68 | — | — | |
| SCHEMBL6902642 | 0.68 | HSPA5 (0.32) | ALDH1A1KDM4ESMN1; SMN2CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2540731-B1 | Volatile group 2 metal precursors | VERSUM MAT US LLC (US) | 2018-02-21 | — | — | EP | disclosed |
| US-8859785-B2 | Volatile group 2 metal precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2540731-A1 | Volatile group 2 metal precursors | Air Products and Chemicals, Inc. (US) | 2013-01-02 | — | — | EP | disclosed |
| US-20110120875-A1 | Volatile Group 2 Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-05-26 | — | — | US | disclosed |
| EP-2256121-A1 | Volatile group 2 metal precursors | Air Products and Chemicals, Inc. (US) | 2010-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110120875-A1 | Volatile Group 2 Metal Precursors | BST2, BMP2, CACNA1G | ALDH1A1 4740/4885KDM4E 2937/4885GLA 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.